Search results :

FAMP

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Codes: None found

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3
Body temperature increased 60% - 69% x x x
Asthenia 9% - 65% x x x
Infection 33% - 44% x x x
Cough 10% - 44% x x x
Fatigue 10% - 38% x x x
Anorexia 7% - 34% x x x
Nausea 31% - 36% x x x
Vomiting 31% - 36% x x x
Dyspnoea 9% - 22% x x x
Pain 20% - 22% x x
Pneumonia 16% - 22% x x x
Chills 11% - 19% x x x
Upper respiratory tract infection 2% - 16% x x
Visual disturbance 3% - 15% x x x
Diarrhoea 13% - 15% x x x
Gastrointestinal haemorrhage 3% - 13% x x x
Sweating increased 1% - 13% x x
Paraesthesia 4% - 12% x x
Pharyngitis 0% - 9% x x
Alveolitis allergic 0% - 6% x x
Haemoptysis 1% - 6% x x
Hyperglycaemia 1% - 6% x x
Malaise 6% - 8% x x x
Hearing impaired 2% - 6% x x
Alopecia 0% - 3% x x
Sleep disorder 1% - 3% x x
Anaphylactic shock 0% - 1% x x
Anaemia x x x
Autoimmune haemolytic anaemia x x x
Aneurysm x x
Angina pectoris x x
Arrhythmia x x x
Arthralgia x x
Bronchitis 0% - 1% x x
Cerebellar syndrome 0% - 1% x x
Transient ischaemic attack x x
Cholelithiasis x x
Coma x x x
Confusional state x x x
Constipation x x
Cytopenia x x
Dysphagia x x
Dehydration 0% - 1% x x
Dysuria x x
Oedema x x x
Toxic epidermal necrolysis x
Epistaxis 0% - 1% x x
Oesophagitis 0% x x
Rash x x x
Fibrosis x x x
Flank pain x x x
Headache 0% - 3% x x
Cardiac failure x
Cardiac failure congestive x x
Haematuria x x x
Haemorrhage 0% - 1% x x
Herpes zoster x
Hyperkalaemia x x x
Hypersensitivity x x x
Hypocalcaemia x x x
Progressive multifocal leukoencephalopathy x
Leukopenia x
Lymphoproliferative disorder x
Myelodysplastic syndrome x
Myocardial infarction x x
Neutropenia x x x
Numbness x
Opportunistic infection x x x
Optic nerve disorder x
Optic neuritis x
Osteoporosis x x
Pancytopenia x x
Pericardial effusion x x x
Neuropathy peripheral x x x
Phlebitis x x
Proteinuria x x
Pruritus x x
Pulmonary fibrosis x x
Renal failure x x x
Seborrhoeic dermatitis x x
Convulsion x
Sinusitis 0% - 5% x x
Stevens-Johnson syndrome x
Stomatitis 0% - 9% x x x
Cerebrovascular accident x x
Supraventricular tachycardia x x
Thrombocytopenia x x x
Tumour lysis syndrome x x x
Urinary tract infection x x
Immunocompromised x
Hepatic failure x x
Agitation x x x
Hyperphosphataemia x x x
Cystitis haemorrhagic x x x
Epstein-Barr virus infection x
Deep vein thrombosis x x
Urate crystalluria x x x
Pulmonary haemorrhage x x
Liver function test abnormal x x
Bone marrow depression x x
Urinary hesitation x x
Haemoglobin decreased x x
Malnutrition x
Metabolic acidosis x x x
Myalgia x x
Wrist drop x x x
Digestion impaired x x x
Neurotoxicity x
Lung infiltration x x x
Renal function test abnormal x x
Hypoxia 0% - 1% x x
Aplasia x x
Mucosal inflammation 0% x x x
Blindness x
Respiratory distress x x
Hyperuricaemia x x x
Myelosuppression x x x
Pulmonary toxicity x x
Respiratory failure x x
Skin toxicity x x
Absolute neutrophil count decreased x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

FLUDARABINE PHOSPHATE / FLUDARA

Side effects:104
Source:FDA

FLUDARABINE PHOSPHATE / FLUDARA

Side effects:104
Source:FDA

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label